Validation Blood Test For Kidney Cancer Diagnosis

Not Applicable

Recruiting

• Conditions: Neoplasms

• Registration Number: KCT0003566
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Those who have has been judged as radiological and histologic kidney cancer
Those who have has been judged as suspicious for radiological and histologic kidney cancer
Those who have read and signed the Clinical Study Agreement and the Study Agreement

Exclusion Criteria

Patients whom the researcher deemed inappropriate for this clinical trial

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expression of NNMT, LCP1, and NM23A in the kidney cancer markers

Secondary Outcome Measures

Name	Time	Method
Only expression of NNMT, a marker of renal cancer